<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02510534</url>
  </required_header>
  <id_info>
    <org_study_id>IVFFL001v2</org_study_id>
    <nct_id>NCT02510534</nct_id>
  </id_info>
  <brief_title>Effect of Luteal Progesterone Support on Pregnancy Rates With Combined Clomid/ Gonadotropin &amp; IUI</brief_title>
  <official_title>A Prospective Randomized Trial to Study the Effect of Luteal Progesterone Support on Pregnancy Rates in Combined Clomiphene Citrate and Gonadotropin Ovulation Induction Protocol With Intrauterine Insemination.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwest Center for Infertility and Reproductive Endocrinology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ferring Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Northwest Center for Infertility and Reproductive Endocrinology</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the difference in clinical pregnancy rates with and without luteal progesterone
      support in a young reproductive aged population having undergone ovulation induction with
      combined clomiphene citrate and gonadotropin protocol with intrauterine insemination.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine the difference in clinical pregnancy rates with and without luteal progesterone
      support in a young reproductive aged population having undergone ovulation induction with
      combined clomiphene citrate and gonadotropin protocol with intrauterine insemination.

      Patients will be randomized in a treatment arm or control arm. The treatment arm receives the
      luteal progesterone support and the control arm does not. Each arm will have 260 patients.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    unable to enroll participants who meet the criteria
  </why_stopped>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect on Pregnancy rate measured by detectable embryonic cardiac activity</measure>
    <time_frame>10 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">520</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This arm receives Menopur 150 international units x 1 dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This arm receives Menopur 150 international units x 1 dose and Endometrin 100mg twice a day x 14 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Menopur 150 international units</intervention_name>
    <description>Menopur 150 international units given x 1 dose</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Treatment</arm_group_label>
    <other_name>Gonadotropin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Endometrin 100 mg</intervention_name>
    <description>Endometrin 100mg twice daily x 14 days</description>
    <arm_group_label>Treatment</arm_group_label>
    <other_name>Progesterone</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-37

          -  BMI 19-34 kg/m2

          -  Day 2-3 Follicle stimulating hormone (FSH) less than 10IU/mL

          -  Estradiol (E2) less than 80 pg/mL

          -  Anti-mullerian hormone (AMH) more than 1.5 ng/mL; or antral follicle count (AFC) up to
             10

          -  Two patent fallopian tubes confirmed by hysterosalpingogram (HSG) or chromopertubation

          -  Normal uterine cavity confirmed by HSG, saline sonohysterogram (SIS) or hysteroscopy

        Exclusion Criteria:

          -  Severe male factor (total count less than 10 million sperm)

          -  Systemic diseases not limited to diabetes

          -  Pregnancy within 3 months

          -  More than 1 prior cycle of gonadotropin treatment

          -  Any ovarian cyst &gt;15mm that has persisted for &gt; 1 month

          -  Endometrioma and/or Endometriosis-stage III or IV

          -  Submucosal uterine fibroids; untreated endometrial polyps &gt;1 cm;abnormal reproductive
             tract bleeding

          -  Intolerance or allergy to study drug

          -  Substance abuse (including alcohol and tobacco)

          -  History of chemotherapy (except for gestational conditions) or radiotherapy

          -  Minors and those adults not capable of consenting on their own
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>37 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Christie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IVF FL</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ivf Florida</name>
      <address>
        <city>Margate</city>
        <state>Florida</state>
        <zip>33063</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 24, 2015</study_first_submitted>
  <study_first_submitted_qc>July 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2015</study_first_posted>
  <last_update_submitted>September 22, 2016</last_update_submitted>
  <last_update_submitted_qc>September 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Progesterone</mesh_term>
    <mesh_term>Menotropins</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

